nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Academia–industry Cooperation in the Medical Field: Matching Opportunities in Japan
|
Tsuruya, Nao |
|
2018 |
40 |
11 |
p. 1807-1812 |
artikel |
2 |
A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine
|
Sawada, Masanori |
|
2018 |
40 |
11 |
p. 1801-1806 |
artikel |
3 |
Are Adverse Events Induced by the Acute Administration of Calcineurin Inhibitor Cyclosporine A Behaviorally Conditioned in Healthy Male Volunteers?
|
Kahl, Anna Lena |
|
2018 |
40 |
11 |
p. 1868-1877 |
artikel |
4 |
Assumptions in Clinical Trial Designs and Therapies
|
Shader, Richard I. |
|
2018 |
40 |
11 |
p. 1789-1795 |
artikel |
5 |
Budget Impact Analysis of a Biosynthetic Mesh for Incisional Hernia Repair
|
Rognoni, Carla |
|
2018 |
40 |
11 |
p. 1830-1844.e4 |
artikel |
6 |
Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261–269]
|
Kidd, James M. |
|
2018 |
40 |
11 |
p. 1956 |
artikel |
7 |
Editorial Board
|
|
|
2018 |
40 |
11 |
p. ii-iii |
artikel |
8 |
Identifying Myocardial Ischemia due to Coronary Microvascular Dysfunction in the Emergency Department: Introducing a New Paradigm in Acute Chest Pain Evaluation
|
Safdar, Basmah |
|
2018 |
40 |
11 |
p. 1920-1930 |
artikel |
9 |
Intellectual Property in the Field of Regenerative Medicine in Japan
|
Asano, Shigehiro |
|
2018 |
40 |
11 |
p. 1823-1827 |
artikel |
10 |
Measurement of Utilities Associated with Parenteral Support Requirement in Patients with Short Bowel Syndrome and Intestinal Failure
|
Ballinger, Rachel |
|
2018 |
40 |
11 |
p. 1878-1893.e1 |
artikel |
11 |
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines
|
Scavone, Cristina |
|
2018 |
40 |
11 |
p. 1931-1940 |
artikel |
12 |
Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study
|
Labetoulle, Marc |
|
2018 |
40 |
11 |
p. 1894-1906 |
artikel |
13 |
Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia
|
Sun, Lei |
|
2018 |
40 |
11 |
p. 1845-1854.e2 |
artikel |
14 |
Preclinical Toxicity Studies for Regenerative Medicine in Japan
|
Shigeto, Jun |
|
2018 |
40 |
11 |
p. 1813-1822 |
artikel |
15 |
Regenerative Medicine at the Forefront of Innovation: Update From Japan
|
Milne, Christopher-Paul |
|
2018 |
40 |
11 |
p. 1798-1800 |
artikel |
16 |
Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers
|
Moreno, Ofir |
|
2018 |
40 |
11 |
p. 1855-1867 |
artikel |
17 |
Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab Treatment
|
Krčmová, Irena |
|
2018 |
40 |
11 |
p. 1942-1953 |
artikel |
18 |
Table of Contents
|
|
|
2018 |
40 |
11 |
p. iv-v |
artikel |
19 |
The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and Stroke
|
Romero, Natasha |
|
2018 |
40 |
11 |
p. 1907-1917.e3 |
artikel |